Recent

% | $
Quotes you view appear here for quick access.

Ohr Pharmaceutical, Inc. Message Board

  • biogenius722 biogenius722 Mar 17, 2014 6:38 PM Flag

    Why every pullback is a buy

    1. No institutional buyer who recently added the stock to their portfolio will sell before interim PIi
    2. Technically, every large up move has been on very significant volume
    3. Every retracement has been on below average volume
    4. Every piece of information that has come out has been positive
    5. The negative information that people like AF have tried to circulate was short lived, old and without backup
    6. No insiders have sold stock
    7. Nationally recognized eye specialists have had only good things to say about Squalamine.

    Do your own dd

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • This needs to be bumped...!!

    • add to bio's list:

      8. Regression of PDR as presented at national ophthalmology conference.
      9. Dr. Katz leak of "amazing results" and patients completely "forgoing" injections.
      10. Patient "Bob" forgoing injections.
      11. Science largely proven by Dr. Livermore10 and confirmed by other medical professionals on this board.
      12. Insiders, who have huge unrealized gains, have not sold a single share. (very telling)
      13. Shelf registration has not been issued despite large share increase (mgmt must believe much higher price is near).
      14. Growing institutional investment.
      15. Investment by eye doctors around the country (as mentioned on the board).

      Feel free to add to this list.

      Sentiment: Strong Buy

      • 1 Reply to dhm3159
      • 16. Increasing evidence that the shots cause Geographic Atrophy over time.
        17. Insurance companies (payers) will welcome a treatment that reduces shots and will encourage its use.
        18. More retina journals publishing serious articles about the potential of squalamine
        19. The bear case cannot produce a list like this

        please add.....

 
OHRP
2.81+0.03(+1.08%)Sep 23 4:00 PMEDT